Geno J. Germano's most recent trade in Sage Therapeutics Inc was a trade of 21,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sage Therapeutics Inc | Geno J. Germano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 21,500 | 21,500 | - | - | Stock Option (Right to Buy) | |
| Precision Biosciences Inc | Geno J. Germano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 21,000 | 21,000 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Geno J. Germano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2025 | 9,826 | 20,883 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Geno J. Germano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2025 | 9,826 | 0 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Geno J. Germano | Director | Purchase of securities on an exchange or from another person at price $ 5.30 per share. | 25 Mar 2025 | 3,250 | 11,057 (0%) | 0% | 5.3 | 17,225 | Common Stock |
| Precision Biosciences Inc | Geno J. Germano | Director | Purchase of securities on an exchange or from another person at price $ 4.49 per share. | 30 Dec 2024 | 3,605 | 7,807 (0%) | 0% | 4.5 | 16,186 | Common Stock |
| Sage Therapeutics Inc | Geno J. Germano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Precision Biosciences Inc | Geno J. Germano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 9,826 | 9,826 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Geno J. Germano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 4,202 | 4,202 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Geno J. Germano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 4,202 | 0 | - | - | Restricted Stock Units | |
| Sage Therapeutics Inc | Geno J. Germano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Precision Biosciences Inc | Geno J. Germano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 126,075 | 126,075 | - | - | Restricted Stock Units | |
| Sage Therapeutics Inc | Geno J. Germano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 9,947 | 9,947 | - | - | Stock Option (Right to Buy) | |
| Precision Biosciences Inc | Geno J. Germano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 156,951 | 156,951 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Geno J. Germano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Precision Biosciences Inc | Geno J. Germano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 32,800 | 32,800 | - | - | Stock Option (Right to Buy) |